ED
CRAY

Exane Derivatives’s Cray, Inc. CRAY Stock Holding History

Exane Derivatives’s Portfolio CRAY Stock Details CRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed -$18 – 665
2017
Q2 		$18 Hold
1
– – ﹤0.01% 617
2017
Q1 		$22 Hold
1
– – ﹤0.01% 547
2016
Q4 		$21 Hold
1
– – ﹤0.01% 614
2016
Q3 		$24 Hold
1
– – ﹤0.01% 595
2016
Q2 		$30 Hold
1
– – ﹤0.01% 513
2016
Q1 		$42 Hold
1
– – ﹤0.01% 558
2015
Q4 		$32 Hold
1
– – ﹤0.01% 478
2015
Q3 		$20 Hold
1
– – ﹤0.01% 514
2015
Q2 		$30 Hold
1
– – ﹤0.01% 507
2015
Q1 		$28 Sell
1
-101
-99% -$3.2K ﹤0.01% 506
2014
Q4 		$3.52K Buy
+102
New +$3.24K ﹤0.01% 449

Other funds holding CRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Exane Derivatives's CRAY Position: Q3 2017 in Review

Exane Derivatives sold out of Cray, Inc. (CRAY) in Q3 2017, closing a stake of 1 share — an estimated $18 sold.

Exane Derivatives first reported a position in CRAY in Q4 2014 and held it in 11 quarters. The position peaked at $3.52K in Q4 2014. 135 funds tracked by Wall St. Rank hold CRAY as of Q3 2017.

  • Exane Derivatives reported no remaining Cray, Inc. position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Cray, Inc. share in Q3 2017, an estimated $18.
  • Exane Derivatives first reported a position in Cray, Inc. in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's Cray, Inc. position peaked at $3.52K in Q4 2014.
  • 135 funds tracked by Wall St. Rank held Cray, Inc. as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.